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Abstract
A case of severe diarrhoea associated with synergistic human bocavirus type 1 (HBoV) and human herpes virus
type 6 (HHV6) is reported. The case supports the hypotheses that HBoV infection under clinical conditions may
depend on helper viruses, or that HBoV replicates by a mechanism that is atypical for parvoviruses, or that HBoV
infection can be specifically treated with cidofovir.
Background
The human bocavirus (HBoV) was discovered in 2005
by the Swedish group of Tobias Allander and colleagues
[1]. By now, HBoV was detected in patients suffering
from respiratory infections and gastrointestinal diseases,
but a proof that HBoV is the causative agent in such
cases is missing as it remains impossible so far to fulfil
Koch’s modified postulates [2]. The latter problem is
caused by the fact that HBoV is hardly to propagate in
cell culture [3] and that no transmission within an ani-
mal model was successful until today.
Since HBoV infections are accompanied by co-patho-
gens in a very high frequency it was postulated that
HBoV is a passenger rather than a pathogen in airway
infections [2], despite of the fact that HBoV causes a
productive infection with viral shedding, viremia, and
putatively persistence in different organs [4-7]. Although
HBoV meanwhile was classified as an autonomous par-
vovirus [3] rather than a Dependovirus like the Adeno-
associated virus (AAV) there remains the possibility that
HBoV infections depend on helper viruses or at least
contributes synergistically to the clinical course. Depen-
doviruses require a helper virus such as the polyoma-
virus SV40, herpes viruses, or adenoviruses, of which
SV40 and Herpesviruses are known to be able to initiate
a rolling circle genome replication [8-12]. A recent
study has demonstrated that HBoV in turn is capable to
form head-to-tail DNA-sequences that on the other
hand are a typical feature of a rolling circle replication.
The presented case report provides evidence that the
HBoV infection is probably dependent on herpesvirus
replication or sensitive to anti-herpesviral therapy with
the nucleotide analogue cidofovir.
Case Report
The patient is a 14 months old Caucasian male with a
known history of a myelosarcoma with affected bone
marrow, recurrent HHV6 pneumonia, and multiple hos-
pitalisations for several reason. Of note, the patient also
suffers from a secondary immunodeficiency with predo-
minant global lack of Immunoglobulins A, G, and M,
which origin is not yet determined.
In January 2011 the patient was hospitalized for severe
pneumonia accompanied by Norovirus-induced gastro-
enteritis with severe diarrhoea. Thereby the hospitalisa-
tion was required as the symptoms of diarrhoea were
recurring since November 2010 and resulted in a stop
of weight gain with the risk of dehydration. The patient
was released from the hospital 3 days later but was re-
hospitalized after four weeks due to aggravation of the
gastrointestinal disease.
Despite reduced body weight the patient’s general
condition was classified as good, however accompanied
by moderate anaemic but partially irritated flaked skin,
reduced turgor, and wheezing, with radiological signs of
an atypical pneumonia (banded shadows in the right
upper lope and moderately reduced ventilation). Anti-
body levels and the blood lymphocyte count were extre-
mely low, whilst monocytes and eosinophiles were
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significantly increased. Serologically, the patient was
tested negative for CMV, EBV, parvovirus B19, and ade-
noviruses but positive for HHV6 with a viremia increas-
ing from 5.3 × 106 to 7.8 × 106 copies per ml serum.
Stool samples were tested negative for rotavirus, adeno-
viruses, norovirus, Clostridium difficile (strains and tox-
ins), Salmonella, Shigella, Yersinia, and Campylobacter
coli/jejuni as well as enteropathogenic E. coli.
Due to the ongoing and severe diarrhoea further ana-
lyses and pathological investigations were initiated.
Thereby, the human herpes virus 6 (HHV6) infection
was confirmed in blood, duodenum, and colon biopsies.
Instead, human bocavirus was detected in stool and,
surprisingly, in duodenum biopsies but not in blood or
colon biopsies. Sequencing analyses and subsequent
blastN revealed that HBoV1 was present with an E-
value of 5 × 10-68 to 3 × 10-65 and a total matching
score ranging between 292 and 297. No further signs for
a pathological disorder were detected. Based on the
pathological and virological diagnoses antiviral therapy
was started with Cidofovir. During this therapy, the
HHV6 viremia decreased but remained detectable in
both serum and stool samples taken in two intervals of
14 days; thereby, most surprisingly, during the Cidofovir
therapy HBoV became undetectable in the stool samples
2 weeks after the onset of the antiviral therapy while
HHV6 remained positive.
Discussion
In the recent past human bocavirus has been frequently
associated with severe diarrhoea and turned out to be a
most frequent agent in this clinical disorder [13-19], lead-
ing to the assumption that HBoV is the causative agent
despite the missing proof of Koch’s postulates for HBoV
[2]. Thereby, mainly the genotypes 2-4 but not genotype
1 cause gastrointestinal infections, whilst the latter is
mainly found in respiratory secretions. This latter obser-
vation is compatible with the fact that a mild respiratory
infection with the clinical picture of a beginning atypical
pneumonia was observed that was characterized by slight
wheezing and radiological signs. The severe diarrhoea
may have been a result of a synergistic interaction
between the HHV6 infection and the superinfection by
human bocavirus. Human herpes virus 6 was described
to be a causative agent for prolonged diarrhoea in high
risk patients [20]; the HHV6 associated diarrhoea may
have been aggravated by the symptoms that are caused
by human bocavirus. Although HBoV genotype 1 is
mainly associated with respiratory infections it appears
possible that in case of immuno-incompetent patients
gastro-intestinal symptoms occur that are usually asso-
ciated with the HBoV genotypes 2-4.
The case described here is interesting and surprising
for two additional reasons: First, the presented case
gives raise to the hypothesis that HBoV in fact repli-
cates in the gastrointestinal tract, in particular in the
duodenum as confirmed by positive PCR results from
the clinical material of duodenum but a negative PCR
for the colon samples. Thus, it appears likely that a
locus for replication of human bocavirus was identified.
Second, the observation that HBoV persisted until the
onset of Cidofovir therapy is of major interest. On the
one hand this observation leads to the hypothesis that
HBoV itself is sensitive to Cidofovir and in turn we
would have a specific drug available that could be
administered in severe clinical cases. Cidofovir was
described to display antiviral activity against DNA
viruses beyond the family of herpesviruses [21,22]. On
the other hand this observation could lead to a more
groundbreaking hypothesis. Recently we have shown
that in clinical samples DNA sequences were detect-
able that are of head-to-tail structure [23]. Head-to-tail
sequences of viral genomes are a typical feature of a
rolling circle replication [24] rather than of a rolling
hairpin as postulated for other parvoviruses [25-27].
The hypothesis that HBoV may replicate in a classical
rolling circle mechanism is supported by the fact that
HBoV genomes are predominantly of negative sense
polarity and that solely a minority of HBoV strains
additionally encapsidates positive stranded progeny
DNA [28]. Notably, rolling circle replication can be
initiated by polyomaviruses and herpesviruses including
HHV6 [29-34], both known to be able to act as helper-
viruses for the dependoviruses, a subfamily of parvo-
viruses that is not able to replicate autonomously
[29-35]. The fact that in the presented case HHV6
accompanied the HBoV infection may consequently
give raise to the hypothesis that HBoV in fact replicates
in a rolling circle mechanism in the inner sense and
that rolling circle replication of HBoV may be triggered
by helperviruses. This assumption is supported by the
fact that HBoV in the majority of clinical cases was
described to be accompanied by at least one co-patho-
gen which in turn led to the ongoing discussion that
HBoV is an innocent bystander rather than a true
pathogen [36-41]. In concert with the observation that
HBoV can replicate autonomously in primary cell cul-
ture [3] the present case report goes beyond and leads
to the conclusion that HBoV infection can occur
autonomously but can be triggered in its severity by
co-infections that in turn may modify the molecular
replication strategy of HBoV. Although some of the
hypotheses presented in this report remain a matter of
speculation until it becomes possible to culture human
bocavirus in a simplified culture system or in an animal
model the presented observation are of major impor-
tance for the treatment of severe infections associated
with HBoV and as thus deserve foremost attention.
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